The BPCA benefits pediatric patients by ensuring that more medications are tested and labeled for use in children. This results in: 1. Improved Safety: Medications undergo rigorous testing to determine safe dosage levels for children. 2. Enhanced Efficacy: Drugs are evaluated for effectiveness in pediatric patients, ensuring they work as intended. 3. Better Information: Healthcare providers have access to more detailed and accurate prescribing information, allowing for more informed treatment decisions.
